A Phase 1b Trial of Dinaciclib in Combination With Rituximab in Subjects With Relapsed and Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Dinaciclib (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Aug 2013 New source identified and integrated (United Kingdom Clinical Research Network record: 13251).
- 14 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.